Allogeneic stem cell transplantation as immunotherapy for X-linked lymphoproliferative disease-associated cerebral T-cell lymphoma

被引:1
作者
Goodyer, Matthew [1 ]
Sargent, Jeremy [1 ]
Bond, Jonathan [1 ]
McMahon, Corrina [1 ]
Dunne, Barbara [2 ]
Smith, Owen [1 ]
机构
[1] Our Ladys Childrens Hosp, Dept Haematol, Crumlin, Ireland
[2] St James Univ Hosp, Dept Histopathol, Dublin, Ireland
关键词
immunotherapy; stem cell transplantation; CNS; lymphoproliferative disease; EPSTEIN-BARR-VIRUS; INFECTION;
D O I
10.1111/bjh.12454
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:133 / 135
页数:3
相关论文
共 11 条
[1]   X-linked lymphoproliferative disease: Clinical, diagnostic and molecular perspective [J].
Gaspar, HB ;
Sharifi, R ;
Gilmour, KC ;
Thrasher, AJ .
BRITISH JOURNAL OF HAEMATOLOGY, 2002, 119 (03) :585-595
[2]   ERADICATION OF EPSTEIN-BARR VIRUS BY ALLOGENEIC BONE-MARROW TRANSPLANTATION - IMPLICATIONS FOR SITES OF VIRAL LATENCY [J].
GRATAMA, JW ;
OOSTERVEER, MAP ;
ZWAAN, FE ;
LEPOUTRE, J ;
KLEIN, G ;
ERNBERG, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (22) :8693-8696
[3]   Complement activation in circulation and central nervous system after Rituximab (Anti-CD20) treatment of B-Cell lymphoma [J].
Harjunpää, A ;
Wiklund, T ;
Collan, J ;
Janes, R ;
Rosenberg, J ;
Lee, D ;
Grillo-López, A ;
Meri, S .
LEUKEMIA & LYMPHOMA, 2001, 42 (04) :731-738
[4]  
HARRINGTON DS, 1987, CANCER-AM CANCER SOC, V59, P1419, DOI 10.1002/1097-0142(19870415)59:8<1419::AID-CNCR2820590807>3.0.CO
[5]  
2-P
[6]   Clinical and virologic characteristics of chronic active Epstein-Barr virus infection [J].
Kimura, H ;
Hoshino, Y ;
Kanegane, H ;
Tsuge, I ;
Okamura, T ;
Kawa, K ;
Morishima, T .
BLOOD, 2001, 98 (02) :280-286
[7]   Deficiency of the proapoptotic SAP function in X-linked lymphoproliferative disease aggravates Epstein-Barr virus (EBV) induced mononucleosis and promotes lymphoma development [J].
Nagy, Noemi ;
Klein, Eva .
IMMUNOLOGY LETTERS, 2010, 130 (1-2) :13-18
[8]   Molecular and cellular pathogenesis of X-linked lymphoproliferative disease [J].
Nichols, KE ;
Ma, CS ;
Cannons, JL ;
Schwartzberg, PL ;
Tangye, SG .
IMMUNOLOGICAL REVIEWS, 2005, 203 :180-199
[9]   X-linked lymphoproliferative syndrome: a genetic condition typified by the triad of infection, immunodeficiency and lymphoma [J].
Rezaei, Nima ;
Mahmoudi, Elham ;
Aghamohammadi, Asghar ;
Das, Rupali ;
Nichols, Kim E. .
BRITISH JOURNAL OF HAEMATOLOGY, 2011, 152 (01) :13-30
[10]  
Sumegi J, 2000, BLOOD, V96, P3118